Lipocine, Inc. Forecast, price target & analysts
Lipocine, Inc. Target price 2026 - Analyst rating & recommendation
Lipocine, Inc. Classifications & Recommendation
Lipocine, Inc. Price Target
| Target Price | $6.12 |
| Price | $2.10 |
| Potential |
191.43%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Lipocine, Inc. 2027 .
The average Lipocine, Inc. target price is $6.12.
This is
191.43%
register free of charge
$6.30
200.00%
register free of charge
$6.06
188.57%
register free of charge
|
|
| A rating was issued by 8 analysts: 6 Analysts recommend Lipocine, Inc. to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Lipocine, Inc. stock has an average upside potential 2027 of
191.43%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2030
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 1.98 | 0.59 |
| 82.32% | 70.30% | |
| Net Margin | -486.36% | -2,472.71% |
| 544,827.27% | 408.41% |
4 Analysts have issued a sales forecast Lipocine, Inc. 2026 . The average Lipocine, Inc. sales estimate is
This results in the following potential growth metrics:
4 Lipocine, Inc. Analysts have issued a net profit forecast 2026. The average Lipocine, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.77 | -1.76 |
| 0.56% | ||
| P/E | negative | |
| EV/Sales | negative |
4 Analysts have issued a Lipocine, Inc. forecast for earnings per share. The average Lipocine, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Current Lipocine, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Sep 21 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Apr 06 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jan 21 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 13 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Aug 20 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jun 27 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jun 10 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Sep 21 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Apr 06 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jan 21 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 13 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Aug 20 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jun 27 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jun 10 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
